Does adding ATG to the GVHD prophylaxis regimen help reduce its incidence?

Bone Marrow Transplant. 2003 Feb;31(4):311; author reply 313. doi: 10.1038/sj.bmt.1703804.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antilymphocyte Serum / therapeutic use*
  • Fanconi Anemia / therapy*
  • Graft vs Host Disease / epidemiology
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / prevention & control*
  • Humans
  • Incidence
  • Stem Cell Transplantation / adverse effects
  • Transplantation, Homologous

Substances

  • Antilymphocyte Serum